Viewing Study NCT01317966


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-26 @ 8:12 PM
Study NCT ID: NCT01317966
Status: WITHDRAWN
Last Update Posted: 2016-04-20
First Post: 2011-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
Sponsor: Ming Hou
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module